Showing results (141-150 of 225) with videos related to

Sort By:
Pageof 23
American Journal of Respiratory and Critical Care Medicine|June 12, 2004
Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold minersElizabeth L Corbett, Salome Charalambous, Vicky M Moloi, et al.
PLOS Global Public Health|August 8, 2024
Factors related to the utilization of digital adherence technologies in tuberculosis care: A qualitative study among adults in DS-TB treatment, health care providers and other key actors in TanzaniaBianca Gonçalves Tasca, Andrew Mganga, Chung Lam Leung, et al.
AIDS (London, England)|September 23, 2003
Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?Gavin J Churchyard, Katherine Fielding, Salome Charalambous, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2025
Xpert MTB/RIF® cycle threshold as a marker of TB disease severity; Implications for TB treatment stratificationDaniel J Grint, Jasvir Dhillon, Philip D Butcher, et al.
The Lancet. Respiratory Medicine|March 19, 2021
Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trialRobert S Wallis, Sibuse Ginindza, Trevor Beattie, et al.
Lancet (London, England)|July 24, 2018
Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trialAnkur Gupta-Wright, Elizabeth L Corbett, Joep J van Oosterhout, et al.
Nature Medicine|November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
JMIR Public Health and Surveillance|July 28, 2025
Engagement With Digital Adherence Technologies as Measures of Intervention Fidelity Among Adults With Drug-Susceptible Tuberculosis and Health Care Providers: Descriptive Analysis Using Data From Cluster-Randomized Trials in Five CountriesJason Alacapa, Amare Worku Tadesse, Natasha Deyanova, et al.
Nature Medicine|November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Tropical Medicine and Infectious Disease|March 26, 2025
Process Evaluation of Pragmatic Cluster-Randomized Trials of Digital Adherence Technologies for Tuberculosis Treatment Support: A Mixed-Method Study in Five CountriesNorma Madden, Amare W Tadesse, Chung Lam Leung, et al.
Pageof 23